Compounds and methods of use for treatment of neurogenic inflammation
US6589957B2 · kind B2 · utility
0Cited by
5References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 31, 2001 |
| Grant date | Jul 8, 2003 |
| Priority date | — |
| Expiry date | Aug 31, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention pertains to compounds which are useful as anti-inflammatory agents and to compositions containing such compounds as active ingredients. The novel uses of the compounds relate to the anti-neurogenic inflammatory properties of the disclosed bis-heterocyclic compounds. Specifically exemplified herein are dragmacidin f, topsentin d, and topsentin e, and their salts, analogs, and derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.